Gonococcal Inflammatory Immune Responses

淋球菌炎症免疫反应

基本信息

项目摘要

DESCRIPTION (provided by applicant): This exploratory R21 application will investigate the significance of the newly described "Th17 axis of immunity" in a mouse model of vaginal gonococcal infection. The objectives are to determine whether Neisseria gonorrhoeae can induce the development of Th17 cells and to test the hypothesis that signaling through the interleukin (IL)-17 receptor is important in the elicitation of the innate immune response. Th17 cells, which produce IL-17, have been shown to play a major role in innate immune/inflammatory responses and in the elicitation of the neutrophil influx in response to mucosal infections. N. gonorrhoeae, the agent of gonorrhea, typically induces a neutrophil influx into the site of infection and the presence in genital secretions of gonococci associated with neutrophils is a classic diagnostic criterion. Like other pathogens, N. gonorrhoeae interacts with host tissues to elicit responses that favor its survival, and the natural infection does not induce protective immunity against repeated infection. It has therefore been suggested that N. gonorrhoeae actively interferes with the development of adaptive immune responses, and it is hypothesized that the elicitation of Th17 cells contributes to this. The Specific Aims are: (1) To evaluate the ability of N. gonorrhoeae to induce the development of Th17 cells and the production of key cytokines in mouse cells in vitro and in vivo, and in human blood mononuclear cells in vitro; (2) To compare the responses of normal wild- type and IL-17 receptor-deficient mice to vaginal challenge with N. gonorrhoeae in order to determine whether signalling through this receptor is critical in the recruitment of neutrophils and in deflecting adaptive immune responses. Elucidation of this novel pathway of the host response to N. gonorrhoeae will greatly improve comprehension of the immuno-pathogenic mechanisms of gonococcal infection and facilitate the development of new interventions against gonorrhea, for which there is a demonstrable need. PUBLIC HEALTH RELEVANCE: Gonorrhea is the second-most-frequent, notifiable infectious disease in the United States and the CDC reports over 300,000 cases in recent years [59], although the true incidence is believed to be double that figure; world- wide incidence is estimated to be over 60 million new infections per year [60]. Women bear the brunt of the infection which can lead to serious reproductive health problems including pelvic inflammatory disease, infertility, and risk for ectopic pregnancy, and while it is well known that gonorrhea does not generate immunity to repeated infection, no vaccines exist to control it and antibiotic resistance is spreading. This proposal will apply important new findings from the field of immunology to determine the way in which the immune system interacts with the gonococcus bacterium, an area that is poorly understood at present.
描述(由申请方提供):该探索性R21申请将研究新描述的“Th 17免疫轴”在阴道淋球菌感染小鼠模型中的意义。目的是确定淋病奈瑟菌是否可以诱导Th 17细胞的发育,并检验通过白细胞介素(IL)-17受体的信号传导在引发先天性免疫应答中的重要性这一假设。产生IL-17的Th 17细胞已被证明在先天免疫/炎症反应中以及在响应于粘膜感染引起中性粒细胞流入中起主要作用。N.淋病病原体淋病通常诱导中性粒细胞流入感染部位,并且生殖器分泌物中存在与中性粒细胞相关的淋球菌是经典的诊断标准。与其他病原菌一样,N.淋病与宿主组织相互作用以引起有利于其存活的反应,并且自然感染不会诱导针对重复感染的保护性免疫。因此,有人建议,N。淋病主动干扰适应性免疫应答的发展,并且假设Th 17细胞的激发对此有贡献。具体目的是:(1)评价N.(2)比较正常野生型和IL-17受体缺陷型小鼠对淋病奈瑟菌阴道攻击的反应。淋病,以确定通过该受体的信号传导是否在中性粒细胞的募集和在偏转适应性免疫应答中是关键的。阐明了这一新的途径的主机响应N。淋病将极大地提高对淋球菌感染的免疫致病机制的理解,并促进抗淋病的新干预措施的开发,这是一个明显的需求。公共卫生关系:淋病是美国第二常见的应报告的传染病,CDC近年来报告了超过30万例病例[59],尽管真实发病率被认为是该数字的两倍;全球发病率估计每年超过6000万例新感染[60]。妇女首当其冲的感染,这可能导致严重的生殖健康问题,包括盆腔炎,不孕不育和异位妊娠的风险,虽然众所周知,淋病不会产生免疫力,反复感染,没有疫苗存在,以控制它和抗生素耐药性正在蔓延。该提案将应用免疫学领域的重要新发现来确定免疫系统与淋球菌细菌相互作用的方式,这是目前知之甚少的领域。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL W RUSSELL其他文献

MICHAEL W RUSSELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL W RUSSELL', 18)}}的其他基金

Imaging antigen and adjuvant uptake for enhancing response to mucosal vaccines
对抗原和佐剂摄取进行成像以增强对粘膜疫苗的反应
  • 批准号:
    8204418
  • 财政年份:
    2010
  • 资助金额:
    $ 19.61万
  • 项目类别:
Imaging antigen and adjuvant uptake for enhancing response to mucosal vaccines
对抗原和佐剂摄取进行成像以增强对粘膜疫苗的反应
  • 批准号:
    8029985
  • 财政年份:
    2010
  • 资助金额:
    $ 19.61万
  • 项目类别:
Gonococcal Inflammatory Immune Responses
淋球菌炎症免疫反应
  • 批准号:
    7582762
  • 财政年份:
    2009
  • 资助金额:
    $ 19.61万
  • 项目类别:
MUCOSAL VACCINES AGAINST GONORRHEA
淋病粘膜疫苗
  • 批准号:
    6374378
  • 财政年份:
    2000
  • 资助金额:
    $ 19.61万
  • 项目类别:
MUCOSAL VACCINES AGAINST GONORRHEA
淋病粘膜疫苗
  • 批准号:
    6511167
  • 财政年份:
    2000
  • 资助金额:
    $ 19.61万
  • 项目类别:
MUCOSAL VACCINES AGAINST GONORRHEA
淋病粘膜疫苗
  • 批准号:
    6406282
  • 财政年份:
    2000
  • 资助金额:
    $ 19.61万
  • 项目类别:
MUCOSAL VACCINES AGAINST GONORRHEA
淋病粘膜疫苗
  • 批准号:
    6632189
  • 财政年份:
    2000
  • 资助金额:
    $ 19.61万
  • 项目类别:
REGULATION OF CELLULAR INFLAMMATORY RESPONSES
细胞炎症反应的调节
  • 批准号:
    6104727
  • 财政年份:
    1998
  • 资助金额:
    $ 19.61万
  • 项目类别:
MATERNAL INFLUENCES ON MUCOSAL IMMUNITY IN INFANTS
母亲对婴儿粘膜免疫的影响
  • 批准号:
    6104901
  • 财政年份:
    1998
  • 资助金额:
    $ 19.61万
  • 项目类别:
MATERNAL INFLUENCES ON MUCOSAL IMMUNITY IN INFANTS
母亲对婴儿粘膜免疫的影响
  • 批准号:
    6238572
  • 财政年份:
    1997
  • 资助金额:
    $ 19.61万
  • 项目类别:

相似海外基金

Ecological and Evolutionary Drivers of Antibiotic Resistance in Patients
患者抗生素耐药性的生态和进化驱动因素
  • 批准号:
    EP/Y031067/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.61万
  • 项目类别:
    Research Grant
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
  • 批准号:
    2307222
  • 财政年份:
    2024
  • 资助金额:
    $ 19.61万
  • 项目类别:
    Standard Grant
Molecular Epidemiology of Antibiotic Resistance in Clostridioides difficile
艰难梭菌抗生素耐药性的分子流行病学
  • 批准号:
    502587
  • 财政年份:
    2024
  • 资助金额:
    $ 19.61万
  • 项目类别:
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
  • 批准号:
    2307223
  • 财政年份:
    2024
  • 资助金额:
    $ 19.61万
  • 项目类别:
    Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
  • 批准号:
    MR/Y013131/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.61万
  • 项目类别:
    Research Grant
Determining structural dynamics of membrane proteins in their native environment: focus on bacterial antibiotic resistance
确定膜蛋白在其天然环境中的结构动力学:关注细菌抗生素耐药性
  • 批准号:
    MR/X009580/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.61万
  • 项目类别:
    Fellowship
CAREER: Systems Microbiology and InterdiscipLinary Education for Halting Environmental Antibiotic Resistance Transmission (SMILE HEART)
职业:阻止环境抗生素耐药性传播的系统微生物学和跨学科教育(SMILE HEART)
  • 批准号:
    2340818
  • 财政年份:
    2024
  • 资助金额:
    $ 19.61万
  • 项目类别:
    Continuing Grant
Reinforcing the battle at the bacterial cell wall: Structure-guided characterization and inhibition of beta-lactam antibiotic resistance signalling mechanisms
加强细菌细胞壁的战斗:β-内酰胺抗生素耐药信号机制的结构引导表征和抑制
  • 批准号:
    480022
  • 财政年份:
    2023
  • 资助金额:
    $ 19.61万
  • 项目类别:
    Operating Grants
The spread of antibiotic resistance in bacteria-plasmid networks
抗生素耐药性在细菌-质粒网络中的传播
  • 批准号:
    BB/X010473/1
  • 财政年份:
    2023
  • 资助金额:
    $ 19.61万
  • 项目类别:
    Fellowship
An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis
用于诊断结核分枝杆菌抗生素耐药性的 RNA 纳米传感器
  • 批准号:
    10670613
  • 财政年份:
    2023
  • 资助金额:
    $ 19.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了